FACTX
Price
$48.60
Change
-$0.86 (-1.74%)
Updated
Apr 3 closing price
Net Assets
3.74B
JNGLX
Price
$66.99
Change
-$0.85 (-1.25%)
Updated
Apr 3 closing price
Net Assets
4.95B
Ad is loading...

FACTX vs JNGLX

Header iconFACTX vs JNGLX Comparison
Open Charts FACTX vs JNGLXBanner chart's image
Fidelity Advisor Health Care M
Price$48.60
Change-$0.86 (-1.74%)
VolumeN/A
Net Assets3.74B
Janus Henderson Global Life Sciences D
Price$66.99
Change-$0.85 (-1.25%)
VolumeN/A
Net Assets4.95B
FACTX vs JNGLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FACTX vs. JNGLX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACTX is a Buy and JNGLX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
JNGLX has more cash in the bank: 4.95B vs. FACTX (3.74B). JNGLX pays higher dividends than FACTX: JNGLX (0.34) vs FACTX (0.00). FACTX was incepted earlier than JNGLX: FACTX (29 years) vs JNGLX (26 years). FACTX (1.18) is less costly to investors than JNGLX (0.80). FACTX is a more actively managed with annual turnover of: 37.00 vs. JNGLX (35.00). FACTX has a lower initial minimum investment than JNGLX: FACTX (0) vs JNGLX (2500). JNGLX annual gain was more profitable for investors over the last year : -6.47 vs. FACTX (-13.54). JNGLX return over 5 years is better than : 35.26 vs. FACTX (9.58).
FACTXJNGLXFACTX / JNGLX
Total Expense Ratio1.180.80147%
Annual Report Gross Expense Ratio1.180.80147%
Fund Existence29 years26 years-
Gain YTD-2.498-0.0743,392%
Front Load4%N/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets3.74B4.95B76%
Annual Yield % from dividends0.000.34-
Returns for 1 year-13.54-6.47209%
Returns for 3 years-13.772.62-526%
Returns for 5 years9.5835.2627%
Returns for 10 years20.3918.94108%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTCCX38.750.31
+0.81%
MFS Technology C
OCSGX6.03N/A
N/A
Optimum Small-Mid Cap Growth C
PEIOX38.93N/A
N/A
Principal Equity Income R3
GGEIX21.85N/A
N/A
Nationwide Global Sust Eq R6
AXVIX16.88N/A
N/A
Acclivity Small Cap Value I